Virus-killing alpha interferon series medicinal cosmetics

A technology for interferon alpha and cosmetics, which is applied in the field of interferon alpha series of pharmaceuticals and cosmetics with the effect of killing viruses, can solve problems such as difficult implementation and incompleteness, and achieve the effects of simple use method, inhibition of replication, and prevention of infection transmission.

Inactive Publication Date: 2003-10-22
CHANGCHUN CHANGSHENG GENE PHARM CO LTD
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Viruses, especially SARS virus, are caused by transmission through the respiratory tract (nose-mouth) and contact. Therefore, it is difficult to control its transmission. Usually, drug sprays, nasal drops, etc. are used, but they are not comprehensive and thorough. An effective and convenient way to prevent virus infection has become a top priority
Cosmetics are directly applied to human skin and have real-time action functions, which can be used as a good measure to implement anti-virus drugs. After searching, there are no series of cosmetic reports that have anti-virus effects, especially on SARS virus.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Alpha-interferon hand cream:

[0013] A. Cetyl alcohol 6.0%, refined beeswax 6.3%, sunflower oil 39.0%, mink oil 6.5%;

[0014] B, methylparaben 0.1%, deionized water balance;

[0015] C. Appropriate amount of flavor;

[0016] D. Alpha-interferon 0.00001-0.005%;

[0017] Appropriate amount of stabilizer; other items should meet the relevant regulations of the cosmetics industry.

[0018] Process: Dissolve component A at 70-80°C, add component B to homogeneously emulsify, cool down to 37°C, add components C and D, homogeneously.

Embodiment 2

[0020] Alpha-interferon moisturizer:

[0021] A, ZY-92 (emulsifier) ​​2.0%, ZY-921 (emulsifier) ​​3.0%, C 16 - 18 OH (16-18 alcohol) 3.0%, white oil 10.0%, DC-200 (emulsifier) ​​0.5%, stearic acid 2.0%, BTH (antioxidant) 0.2%;

[0022] B, glycerin 3.0%, xanthan gum 0.1%, EDTA-2Na (disodium ethylenediaminetetraacetic acid) 0.1% water balance;

[0023] C. Triethanolamine 0.25%, Jimei 0.2%,

[0024] D. Alpha-interferon 0.00001-0.005%;

[0025] Appropriate amount of stabilizer; other items should meet the relevant regulations of the cosmetics industry.

[0026] Process: Dissolve component A in a water bath at 70-80°C. Dissolve xanthan gum and disodium ethylenedione tetraacetate in a water bath for component B with glycerin. Pour A into B, homogeneously emulsify, and cool down Add components C and D, homogeneously.

Embodiment 3

[0028] Alpha-Interferon Eye Cream

[0029] A, PEA (emulsifier) ​​2.0%, IPP (isopropyl palmitate) 5.0%, synthetic squalane 2.0%, C 16 - 18 OH (16-18 alcohol) 1.0%;

[0030] B, AVC (acrylic acid polymer) 1.0%;

[0031] C. Polylift (skin tightening agent) 3.0%, Fermiskin (wrinkle removing agent) 1.0%, extremely beautiful 1.0%, water balance;

[0032] D. Alpha-interferon 0.00001-0.005%;

[0033] Appropriate amount of stabilizer; other items should meet the relevant regulations of the cosmetics industry.

[0034] Process: Heat and dissolve component B with some deionized water, stir evenly, dissolve component A in a water bath at 70-80°C, pour component A into component B, stir evenly, cool down to 45°C, add B, C , components, and stir evenly.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides an alpha-interferon series medicinal cosmetics with the action of killing virus, in which alpha-interferon content in every gram of cosmetic is 0.0001-0.05 mg, its active unt is 10000 IU-5000000 IU / g, and its purity is 85%-99.52%. The described alpha-interferon includes 23 subtype series alpha-interferons belonged to alpha, alpha 2a, alpha 2b and others. Said alpha-interferon is combined in the cosmetics, and can be made into compound functional medicine series cosmetics. These cosmetics can be applied on the face, eye portion, mouth portion, nasal part periphery and hand portion, and can inhibit the replication of virus on those regions, so that it can prevent viral infection and propagation, including SARS virus.

Description

Technical field: [0001] The invention relates to a cosmetic that can kill viruses including SARS virus, specifically provides a series of alpha interferon pharmaceutical cosmetics with the effect of killing viruses, and belongs to the technical field of pharmaceutical series cosmetics and preparation technology. Background technique: [0002] Viruses, especially SARS virus, are caused by transmission through the respiratory tract (nose-mouth) and contact. Therefore, it is difficult to control its transmission. Usually, drug sprays, nasal drops, etc. are used, but they are not comprehensive and thorough. An effective and convenient method for preventing virus infection has become a top priority. Cosmetics are directly applied on people's skin, have real-time action functions, and can be used as a good measure for implementing antiviral drugs. After searching, there are no serial cosmetic reports with antiviral effects, especially on SARS virus. Invention content: [0003] ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Inventor 冯秀萍杨倩杨美华
Owner CHANGCHUN CHANGSHENG GENE PHARM CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap